Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Journal of Clinical Pharmacology
|
September 5, 2022
Comparative Risks of Nonsteroidal Anti-inflammatory Drugs on Cardiovascular Diseases: A Population-Based Cohort Study
Eric Yuk Fai Wan, Esther Yee Tak Yu, Linda Chan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 29, 2021
Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD
Eric Yuk Fai Wan, Esther Yee Tak Yu, Linda Chan, et al.
Scientific Reports
|
April 14, 2021
Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study
Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, et al.
Diabetes, Obesity & Metabolism
|
February 21, 2024
Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
Eric Yuk Fai Wan, Wanchun Xu, Anna Hoi Ying Mok, et al.
Journal of Travel Medicine
|
October 17, 2022
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Emerging Microbes & Infections
|
May 3, 2023
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
The Lancet. Healthy Longevity
|
July 11, 2022
Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series
Eric Yuk Fai Wan, Yuan Wang, Celine Sze Ling Chui, et al.
Cell Reports. Medicine
|
September 16, 2023
Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Drug Safety
|
October 2, 2022
mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
Eric Yuk Fai Wan, Celine Sze Ling Chui, Anna Hoi Ying Mok, et al.
Annals of Internal Medicine
|
March 13, 2023
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 : A Target Trial Emulation Study
Eric Yuk Fai Wan, Vincent Ka Chun Yan, Anna Hoi Ying Mok, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Journal of Clinical Pharmacology
|
September 5, 2022
Comparative Risks of Nonsteroidal Anti-inflammatory Drugs on Cardiovascular Diseases: A Population-Based Cohort Study
Eric Yuk Fai Wan, Esther Yee Tak Yu, Linda Chan, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
April 29, 2021
Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD
Eric Yuk Fai Wan, Esther Yee Tak Yu, Linda Chan, et al.
Scientific Reports
|
April 14, 2021
Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study
Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, et al.
Diabetes, Obesity & Metabolism
|
February 21, 2024
Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
Eric Yuk Fai Wan, Wanchun Xu, Anna Hoi Ying Mok, et al.
Journal of Travel Medicine
|
October 17, 2022
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Emerging Microbes & Infections
|
May 3, 2023
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case-control study
Vincent Ka Chun Yan, Eric Yuk Fai Wan, Xuxiao Ye, et al.
The Lancet. Healthy Longevity
|
July 11, 2022
Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series
Eric Yuk Fai Wan, Yuan Wang, Celine Sze Ling Chui, et al.
Cell Reports. Medicine
|
September 16, 2023
Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study
Eric Yuk Fai Wan, Anna Hoi Ying Mok, Vincent Ka Chun Yan, et al.
Drug Safety
|
October 2, 2022
mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
Eric Yuk Fai Wan, Celine Sze Ling Chui, Anna Hoi Ying Mok, et al.
Annals of Internal Medicine
|
March 13, 2023
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 : A Target Trial Emulation Study
Eric Yuk Fai Wan, Vincent Ka Chun Yan, Anna Hoi Ying Mok, et al.
Page
of 2